Literature DB >> 32159861

Association between myocarditis and other immune-related adverse events secondary to immune checkpoint inhibitor use.

Avirup Guha1,2,3, Sadeer Al-Kindi1,2,3, Prantesh Jain3,4, Nour Tashtish2, Chantal ElAmm1,2,3, Guilherme H Oliveira5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32159861     DOI： 10.1002/ijc.32960

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  2 in total

Review 1.  Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies.

Authors:  Daniel Ronen; Aseel Bsoul; Michal Lotem; Suzan Abedat; Merav Yarkoni; Offer Amir; Rabea Asleh
Journal:  Vaccines (Basel)       Date:  2022-03-31

Review 2.  Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review.

Authors:  Courtney M Campbell; Avirup Guha; Tamanna Haque; Tomas G Neilan; Daniel Addison
Journal:  J Clin Med       Date:  2020-09-11       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.